<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.0" width="586.0" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 450.8789978027344 205.4550018310547 L 455.6409912109375 205.4550018310547 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 547.427001953125 166.4499969482422 L 556.8939819335938 166.4499969482422 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="200.012,205.492,210.552,216.032,219.532,223.862,229.132,234.402,238.632,242.342,246.572,252.052,256.282,260.55199999999996,262.77,267.1,272.58,277.89,280.061,282.721,285.701,289.341,291.57,296.84,301.07,304.05,308.28,311.99,320.17,322.83,328.31,332.64,338.12,341.1,344.74,346.959,351.289,359.469,364.529,370.009,374.689,376.892,382.992,388.822,391.009,396.169,400.499,403.479,406.139,410.369,415.849,418.829,422.469,424.684,429.014,431.994,434.974,439.204,444.684,449.954,452.614,458.094,462.774,464.993,470.673,473.653,478.923,481.583,486.643,491.803,494.463,498.793,504.313,506.548,511.818,516.048,520.378,522.838,525.818" y="541.48" svg_rhmargin="531.128" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">non-adherence and its determinants among TB patients attending Ethiopian health</text>
  <text x="200.012,202.672,208.152,211.752,214.732,217.392,220.372,225.642,228.622,231.282,236.342,241.822,245.422" y="554.462" svg_rhmargin="247.712" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">institutions.</text>
  <text x="211.974,217.244,220.954,225.184,230.244,235.514,239.744,245.224,248.204,250.664,255.244,257.498,262.768,266.368,270.598,275.908,278.077,283.347,287.577,290.447,293.107,298.587,301.247,304.227,306.887,311.947,317.467,319.689,324.749,327.65900000000005,329.837,335.317,340.377,345.857,349.357,353.687,358.957,364.227,368.457,372.167,376.397,381.877,386.107,390.377,392.653,395.313,398.953,401.1,405.47,407.676,412.836,417.166,420.146,422.806,427.036,432.516,435.536,437.723,444.553,449.823,454.923,457.112,462.382,466.712,472.022,474.233,482.413,485.073,488.673,492.273,496.503,501.813,503.997,508.747,513.497,521.097,523.272,528.332,532.082,534.271,542.451,547.511,551.221,555.491,557.685,562.745" y="567.4449999999999" svg_rhmargin="565.655" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Frequently used definition of non-adherence is a patient who had missed 10% or more of</text>
  <text x="200.012,202.992,208.262,212.532,214.695,217.675,222.735,225.715,230.045,232.545,234.707,239.867,243.577,247.807,251.407,255.637,259.347,262.007,267.067,271.297,276.607,278.871,284.141,289.201,292.801,297.031,300.671,302.852,307.912,310.822,313.0,319.1,324.93,327.116,332.386,336.096,341.366,346.006,349.606,351.896,354.102,358.332,362.872,367.102,372.62199999999996,374.795,377.455,380.365,382.562,385.222,388.24199999999996,390.442,393.102,396.74199999999996,398.889,402.599,406.829,411.059,416.119,424.299,432.479,436.709,442.189,447.459,451.689,456.999,459.267,462.247,467.517,471.847,474.86699999999996,477.011,481.241,485.781,490.011,493.721,498.301,500.539,506.639,512.469,514.598,519.758,524.088,527.068,529.728,533.958,539.438,542.458,544.702,548.302,553.572,558.632,563.902,566.362" y="580.484" svg_rhmargin="571.672" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">the total prescribed doses of TB drugs, even if it is recommended that every TB patient should</text>
  <text x="200.012,204.342,209.612,214.882,219.112,222.822,227.092,229.265,232.245,237.345,239.526,243.856,249.336,252.316,254.976,258.476,264.576,270.406,272.635,280.815,285.045,290.315,292.975,297.205,301.535,304.515,307.175,312.235,317.755,319.973,325.033,329.613,331.822,334.692,339.752,342.212,344.672,349.732,356.562,359.222,364.702,369.382,371.62,374.6,379.87,384.14,386.303,393.653,401.113,407.213,412.00300000000004,414.196,417.796,420.776,424.486,428.816,431.796,436.026,440.666,445.246,447.475,450.865,455.615,459.005,461.295,463.462,470.812,475.872,481.352,484.852,489.182,494.452,499.722,503.952,507.662,511.892,517.372,521.602,525.872,528.148,531.128,536.2280000000001,538.353,542.683,548.163,551.143,553.803,557.303,563.403" y="593.467" svg_rhmargin="569.233" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">adhere to anti-TB medication by following the DOTS strategy [1]. Non-adherence to anti-TB</text>
  <text x="200.012,202.992,206.702,210.932,215.262,218.242,226.422,230.652,236.132,239.15200000000002,241.34,249.52,252.18,256.82,262.09,265.10999999999996,267.362,269.822,274.052,278.382,283.692,285.844,288.824,293.92400000000004,296.105,300.435,305.955,308.124,310.784,316.264,320.494,324.204,328.434,332.764,336.364,340.594,345.904,348.149,351.859,354.519,358.119,363.119,365.27,370.33,373.24,375.418,380.688,384.398,389.668,394.348,396.565,400.275,404.505,408.105,410.765,414.365,417.345,421.675,427.155,431.385,435.655,437.893,442.223,447.703,453.013,455.185,459.555,461.704,466.864,470.574,475.634,478.094,483.154,488.634,493.274,497.504,502.814,505.074,507.734,513.214,516.084,520.314,524.544,527.524,530.184,535.244,540.514,544.114,549.594,553.824,557.424,561.024,563.314,565.565,568.225" y="606.4490000000001" svg_rhmargin="573.745" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">treatment might lead to an increased risk of drug resistance and a prolonged infectiousness, in</text>
  <text x="200.012,204.342,209.612,214.882,217.542,220.522,223.182,228.242,233.762,235.955,238.935,244.035,246.216,249.926,254.156,256.616,260.946,266.106,269.706,273.976,276.206,280.536,286.016,291.326,293.498,298.768,302.998,307.328,310.308,315.578,317.868,320.086,326.186,331.456,336.726,340.326,342.61600000000004,344.804,350.074,354.404,357.384,361.754,363.91,368.97,374.03,377.01,381.34,384.0,389.48,393.71,399.02,401.27,404.14,407.85,412.91,421.13000000000005,423.323,426.303,431.573,434.233,437.873,440.048,443.758,447.988,452.528,455.188,459.418,466.288,468.507,471.167,474.80699999999996,477.011,481.241,484.841,488.441,492.671,498.151,501.131,503.791,508.121,510.621,512.841,515.711,520.771,524.521,526.674,531.834,534.294,538.624,544.104,549.584,552.244,557.724,562.364" y="619.488" svg_rhmargin="564.654" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">addition to relapse and death. Thus, data obtained from this review is essential for planning,</text>
  <text x="200.012,202.672,210.852,216.012,218.472,222.702,230.882,235.112,240.592,243.572,246.232,251.712,256.392,258.632,262.962,268.442,273.752,275.923,280.153,284.693,289.023,291.483,296.753,301.083,304.063,306.723,312.203,316.883,319.123,323.453,328.723,333.263,338.323,342.553,346.883,351.113,355.653,357.94300000000004,360.168,364.398,369.458,377.638,385.818,391.088,396.568,399.228,403.458,407.788,410.768,413.428,418.488,424.008,426.328,430.658,436.138,441.448,443.619,447.219,452.279,456.509,459.169,463.499,465.999,468.167,476.347,481.407,486.467,489.127,491.587,494.247,498.367,502.697,505.677,508.337,513.397,518.917,521.232,528.062,533.122,536.832,541.832,544.022,547.412,552.162,556.912,560.302" y="632.471" svg_rhmargin="562.592" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">implementing and evaluating advocacy, communication and social mobilization work [39].</text>
  <text x="211.974,218.074,223.344,227.614,229.832,232.702,235.362,240.842,246.112,248.772,254.252,258.932,261.126,263.996,267.706,272.766,280.98600000000005,283.179,286.159,291.429,294.089,297.729,299.96,303.56,306.54,311.81,317.08,321.65999999999997,323.828,327.428,332.698,337.758,344.588,348.818,354.128,356.37,359.35,364.62,368.95,371.96999999999997,374.114,378.864,383.614,385.864,390.614,395.364,402.964,405.182,410.242,413.15200000000004,415.33,421.43,427.26,429.446,434.606,438.936,441.916,444.576,448.806,454.286,457.266,460.906,463.122,468.392,471.052,476.362,478.542,484.022,489.082,492.102,494.303,498.633,503.903,509.173,513.403,517.113,521.383,523.556,526.536,531.636,533.817,538.147,543.627,546.607,549.307,551.505,557.605" y="645.454" svg_rhmargin="563.435" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">The finding from this study showed that 21.29% of TB patients did not adhere to anti TB</text>
  <text x="200.012,205.282,208.992,214.262,218.902,222.502,224.792,226.997,233.207,237.437,242.077,244.737,249.797,255.277,259.607,262.107,264.301,268.841,273.171,276.881,279.541,283.871,286.851,289.511,294.571,300.091,302.342,305.002,310.522,312.716,318.196,323.256,328.736,332.236,336.566,341.836,347.106,351.336,355.046,359.276,364.756,368.986,373.256,375.475,378.455,383.555,385.736,390.066,395.546,398.526,401.226,403.424,409.524,415.354,417.484,425.664,429.894,435.164,437.824,442.054,446.384,449.364,452.024,457.084,462.604,464.879,471.709,476.039,479.679,481.887,486.947,492.007,495.607,499.837,503.547,508.087,512.317,517.587,519.877,522.082,525.062,530.332,534.602,536.765,542.035,544.695,549.335,554.605,558.835,562.435" y="658.4929999999999" svg_rhmargin="565.455" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">drugs. Regional variation in non-adherence to anti TB medication was observed, the highest</text>
  <text x="200.012,205.172,208.882,213.112,217.652,221.982,224.442,228.672,234.152,238.382,242.65200000000002,244.855,249.915,252.825,255.003,260.483,265.543,271.023,274.523,278.853,284.123,289.393,293.623,297.333,301.563,307.043,311.273,315.543,317.762,321.152,325.902,330.652,332.902,337.652,342.402,349.962,353.392,355.633,362.463,366.793,370.433,372.64,376.35,380.58,385.74,390.8,394.51,397.49,401.72,407.03000000000003,409.207,411.867,417.387,419.582,424.332,429.392,434.662,437.642,442.912,447.142,450.852,456.37199999999996,458.586,465.936,470.266,473.246,475.906,480.966,486.446,490.086,492.318,496.648,502.128,507.438,509.61,516.96,521.29,524.27,526.93,531.99,537.47,541.8,544.26,546.92,549.9,552.56,556.79,560.43,562.674,567.734" y="671.476" svg_rhmargin="570.644" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">prevalence of non-adherence (18.25%) was reported in Southern Nations and Nationalities of</text>
  <text x="200.012,205.692,208.672,213.942,216.602,221.662,226.822,229.482,233.812,236.102,238.336,243.086,247.836,250.086,254.836,259.586,267.18600000000004,269.403,272.273,277.333,279.793,282.253,287.313,294.143,298.373,303.683,305.857,310.917,315.49699999999996,317.705,323.805,326.465,331.105,334.815,339.145,343.72499999999997,345.938,349.648,353.878,358.518,361.178,366.238,371.758,373.944,380.774,383.434,386.414,391.724,393.9,398.27,400.476,405.636,409.346,413.576,418.116,422.446,424.906,429.136,434.616,438.846,443.116,445.32,450.38,453.29,455.468,460.218,464.968,467.218,471.968,476.718,484.31800000000004,486.536,490.866,496.346,501.656,503.827,506.807,512.077,516.347,518.51,520.97,525.2,529.53,533.13,536.15,538.353,545.183,549.513,553.153,555.36,558.02" y="684.458" svg_rhmargin="563.54" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Ethiopia, 23.61% followed by Tigray region with a prevalence of 22.87% and the least was in</text>
  <text x="200.012,206.842,215.022,220.292,224.622,228.332,232.702,234.934,238.534,241.514,246.784,252.054,254.714,258.944,262.584,264.754,269.504,274.254,276.504,281.254,288.814,291.10400000000004,293.327,299.427,304.697,307.357,310.997,313.17,317.4,321.73,327.25,329.441,334.501,338.77099999999996,340.949,346.109,348.569,352.899,358.169,361.769,364.429,369.489,371.949,376.529,378.763,382.993,387.633,392.793,395.253,399.583,402.243,407.723,411.953,417.263,419.468,424.528,429.108,431.317,434.297,439.567,443.837,446.001,448.871,453.201,457.431,460.45099999999996,462.668,465.648,470.918,475.248,478.268,480.413,483.393,488.663,493.723,498.993,503.633,508.943,511.14,513.6,516.26,519.13,523.4,525.597,528.257,533.7769999999999,535.972,542.802,550.982,556.252,560.582,564.292" y="697.441" svg_rhmargin="568.662" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Amhara studies 10.0%. This can be plausibly explained by the fact that though life in Amhara</text>
  <text x="200.012,202.882,207.212,210.922,219.102,221.762,227.242,231.922,234.14,237.74,242.8,247.03,249.69,253.92,256.9,261.47999999999996,263.677,266.337,269.977,272.181,277.451,281.781,285.491,290.761,293.05100000000004,295.255,303.435,307.765,313.245,317.825,319.973,326.803,334.983,340.253,344.583,348.293,352.623,354.763,358.40299999999996,360.678,363.658,368.718,373.778,378.778,380.974,389.154,393.384,398.654,401.314,405.544,409.874,412.854,415.514,420.574,426.094,428.312,432.642,437.802,442.962,446.672,451.732,456.892,460.602,463.262,467.592,470.572,474.802,477.262,481.842,484.098,487.698,490.358,495.838,500.068,504.33799999999997,506.548,509.528,514.798,519.028,523.6080000000001,525.767,531.037,536.1370000000001,538.353,543.833,548.893,551.913,554.057,560.887,565.217,570.697" y="710.48" svg_rhmargin="573.717" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">farming society is hard, many Amharaâ€™s took medication appropriately since they do not want</text>
  <path d=" M 576.0 291.8800048828125 L 36.0 291.8800048828125 L 36.0 292.3800048828125 L 576.0 292.3800048828125" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d=" M 36.0 278.8160095214844 L 188.50399780273438 278.8160095214844 Z " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d="M450.878 594.544 L455.64 594.544 M547.427 633.55 L556.893 633.55 M576.0 508.119 L36.0 508.119 L36.0 507.619 L576.0 507.619 M36.0 521.183 L188.503 521.183 " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="36.0" y="86.009" height="405.071" width="540.0" title="10"/>
  <text x="36.0" y="86.009" class="image" id="image.10.1" width="540" height="405">image.10.1.36_576.86_491</text>
  <text x="36.0,40.376,42.664,46.576,48.245,52.205,54.205,56.806,61.182,65.302,68.51,71.966,75.006,77.75,79.426,83.802,86.01,90.13,92.874,94.62,98.996,102.452,106.828,109.116,112.492,115.196,117.484,121.833,125.745,127.501,130.541,134.917,139.125,142.997,146.205,150.325,154.601,159.017,160.723,164.427,168.883,172.587,174.795,178.499,181.539,183.827,186.907,188.56,192.68,195.344,197.064,201.52,205.639,210.095,212.799,216.503,220.879,225.255,228.711,231.919,235.375,239.753,243.129,246.625,248.313,251.017,255.177,256.874,260.578,265.034,267.738,270.066,271.784,276.904,281.984,283.69,290.394,293.85,298.226,300.514,303.889,307.593,310.297,312.585,316.629,321.125,322.864,325.152,329.64799999999997,331.312,335.935,338.639,343.015,345.303,349.423,353.799,356.087,359.831,361.529,365.233,368.609,371.985,376.105,379.313,383.688,385.976,390.328,394.23999999999995,395.998,398.702,402.862,404.559,407.263,411.638,415.13399999999996,416.804,419.012,423.132,426.508,430.212,432.916,435.204,439.324,443.82,445.491,449.611,452.275,453.995,456.699,461.075,464.57099999999997,466.297,469.337,472.041,476.417,480.793,483.081,486.537,489.61699999999996,491.241,494.945,497.985,501.025,504.481,507.521,510.561,514.017,518.393" y="504.63" svg_rhmargin="520.393" style="fill:#000000;font-family:MinionPro-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">Fig 4. Forest plot depicting subgroup analysis of non-adherence to anti TB medication in Ethiopia according to the location of the studies assessed.</text>
  <text svg_rhmargin="188.704" x="36.0,39.8,41.848,43.896,47.696,51.072,52.872,54.92,56.968,60.768,64.46,66.004,67.804,71.604,74.067,77.867,79.915,83.715,87.515,89.315,93.115,96.915,100.715,104.515,106.563,107.999,111.799,115.599,118.063,121.863,125.239,126.783,128.583,132.383,136.183,139.983,143.262,145.062,148.862,152.662,156.462,160.262,164.062,167.862,171.661,173.461,177.261,181.061,184.704,188.704" y="54.20500000000004" style="fill:#3a5aa6;font-family:Helvetica-Condensed;font-size:8.0px;font-style:NORMAL;font-weight:normal;">https://doi.org/10.1371/journal.pone.0210422.g004 </text>
  <path d=" M 576.0 737.0999755859375 L 36.0 737.0999755859375 L 36.0 737.5999755859375 L 576.0 737.5999755859375" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d="M576.0 62.9 L36.0 62.9 L36.0 62.4 L576.0 62.4 " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="36.0" y="35.042" height="23.698" width="107.15" title="10"/>
  <text x="36.0" y="35.042" class="image" id="image.10.2" width="107" height="23">image.10.2.36_143.35_59</text>
  <text x="279.836,285.124,287.748,292.124,296.084,300.46,302.164,306.54,310.916,314.758,319.174,320.881,325.257,329.633,334.049,335.734,340.11,344.486,346.694,351.07,353.694,360.318,362.022,366.292,370.668,375.044,377.252,381.252,382.96,387.335,389.58299999999997,391.293,395.669,400.045,402.253,403.957,406.581,408.789,413.165,417.541,421.794,424.418,428.378,432.754,434.458,438.834,442.794,444.498,448.498,450.197,452.405,455.029,459.405,463.781,465.989,472.613,476.989,481.365,483.613,485.233,489.609,493.985,498.361,500.985,505.361,509.737,514.113,518.489,521.006,525.382,529.758,533.718,538.134,539.771,541.475,545.8910000000001,547.595,552.883,555.091,559.467,561.171,565.547,569.923,571.627" y="54.20500000000004" svg_rhmargin="576.043" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia</text>
  <path d=" M 36.0 48.00019836425781 L 576.0 48.00019836425781 L 576.0 47.50019836425781 L 36.0 47.50019836425781" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d=" M 81.58110046386719 34.92279815673828 L 237.88299560546875 34.92279815673828 Z " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <text x="36.0,41.288,45.664,51.872,57.2,58.847,65.055,70.759,76.087,77.782,79.862,81.58,85.956,88.164,90.372,94.748,98.708,100.916,103.124,105.332,109.708,114.084,115.788,117.996,122.372,124.893,129.269,131.477,135.853,140.229,142.437,146.813,151.189,155.451,159.827,162.035,163.739,168.115,172.491,175.115,179.491,183.867,185.571,187.779,192.155,196.44,200.816,205.191,207.399,211.775,216.151,220.527,224.903,229.151,233.527,237.94299999999998,245.876,249.836,254.212,258.588,262.964,267.34,269.964,273.964,275.639,280.015,284.391,286.639,288.338,292.714,297.09,301.466,305.882,552.81,557.185,561.601,563.241,565.489,567.209,571.585" y="764.0" svg_rhmargin="576.001" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PLOS ONE | https://doi.org/10.1371/journal.pone.0210422 January 10, 2019 10 / 15</text>
 </g>
</svg>
